Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun 12;23(1):e0172.
doi: 10.1097/CLD.0000000000000172. eCollection 2024 Jan-Jun.

Drug-induced autoimmune-like hepatitis

Miren García-Cortés  1   2 , Jose M Pinazo-Bandera  1   2 , M Isabel Lucena  1   2 , Raúl J Andrade  1   2
Affiliations
Review

Drug-induced autoimmune-like hepatitis

Miren García-Cortés et al. Clin Liver Dis (Hoboken). .

Abstract

PubMed Disclaimer

Conflict of interest statement

Miren García-Cortés advises and received grants from Gilead Sciences S.L.U. She received grants from AbbVie. The remaining authors have no conflicts to report.

Figures

None
Graphical abstract
FIGURE 1
FIGURE 1
Management algoritm of liver disease with DILI suspicion and autoimmune features. Abbreviations: AIH, autoimmune hepatitis; ANA, antinuclear antibody; anti-LKM1, anti-liver-kidney microsomal type 1 antibody; anti-SLA/LP, anti-soluble liver antigen/liver pancreas antigen; ASMA, anti-smooth muscle; DI-ALH, drug-induced autoimmune-like hepatitis; HDS, herbal and dietary supplements.
See this image and copyright information in PMC

References

    1. García‐Cortés M, Ortega‐Alonso A, Matilla‐Cabello G, Medina‐Cáliz I, Castiella A, Conde I, et al. . Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries. Liver Int. 2023;43:1749–1760. - PubMed
    1. Björnsson E, Talwalkar J, Treeprasertsuk S, Kamath PS, Takahashi N, Sanderson S, et al. . Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology. 2010;51:2040–2048. - PubMed
    1. De Boer YS, Kosinski AS, Urban TJ, Zhao Z, Long N, Chalasani N, et al. . Features of autoimmune hepatitis in patients with drug-induced liver injury. Clin Gastroenterol Hepatol. 2017;15:103–112 e2. - PMC - PubMed
    1. Björnsson ES, Bergmann O, Jonasson JG, Grondal G, Gudbjornsson B, Olafsson S. Drug-induced autoimmune hepatitis: response to corticosteroids and lack of relapse after cessation of steroids. Clin Gastroenterol Hepatol. 2017;15:1635–1636. - PubMed
    1. Rodrigues S, Lopes S, Magro F, Cardoso H, Horta e Vale AM, Marques M, et al. . Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases. World J Gastroenterol. 2015;21:7584–7588. - PMC - PubMed